Comparative Evaluation of the Antimicrobial Susceptibility Patterns of Community-and Hospital-Acquired MRSA from USA Hospitals by Site of Infection: Results from AWARE (2012-2014)
Comparative Evaluation of the Antimicrobial Susceptibility Patterns of Community-and Hospital-Acquired MRSA from USA Hospitals by Site of Infection: Results from AWARE (2012-2014), Lead author: Sader HS, presented at ID Week, October 7-11, 2015, San Diego, CA
In Vitro Activity of Minocycline Against A. baumannii, S. maltophilia and B. cepacia Isolated in 2013 from a Global Surveillance Program
In Vitro Activity of Minocycline Against A. baumannii, S. maltophilia and B. cepacia Isolated in 2013 from a Global Surveillance Program, Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
CAZ-AVI Activity Against CAZ-NS Citrobacter spp., Enterobacter spp,. S. marcescens, and P. aeruginosa from USA (2011-2014)
CAZ-AVI Activity Against CAZ-NS Citrobacter spp., Enterobacter spp,. S. marcescens, and P. aeruginosa from USA (2011-2014), Lead author: Sader HS, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of Omadacycline Tested against Streptococcus pneumoniae from a Global Surveillance Porgram (2014)
Activity of Omadacycline Tested against Streptococcus pneumoniae from a Global Surveillance Porgram (2014), Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of ceftolozane/tazobactam against Enterobacteriaceae, P. aeruginosa and S. pneumoniae from USA and EU Hospitals (2014)
Activity of ceftolozane/tazobactam against Enterobacteriaceae, P. aeruginosa and S. pneumoniae from USA and EU Hospitals (2014), Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
In Vitro Activity of Delafloxacin Tested Against Streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrhalis
In Vitro Activity of Delafloxacin Tested Against Streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrhalis, Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
ß-Lactamase Characterization Enterobacteriaceae Baseline Pathogens from Two Phase 3 Trials of CAZ-AVI
ß-Lactamase Characterization Enterobacteriaceae Baseline Pathogens from Two Phase 3 Trials of CAZ-AVI, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of Meropenem/RPX7009 Against Contemporary Enterobacteriaceae Isolates Collected from BSI in USA Hospitals
Activity of Meropenem/RPX7009 Against Contemporary Enterobacteriaceae Isolates Collected from BSI in USA Hospitals, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of CAZ-AVI against Contemoprary PSA from USA Medical Centers by Census Region
Activity of CAZ-AVI against Contemoprary PSA from USA Medical Centers by Census Region, Lead author: Huband MD, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of Fusidic Acid against Staphylococci Isolated from Patients in United States Hospitals During 2014
Activity of Fusidic Acid against Staphylococci Isolated from Patients in United States Hospitals During 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Trends in ß-Lactamase Occurrence in USA (2012-2014) and Activity of CAZ-AVI Against a Large Collection of BL Producing Isolates
Trends in ß-Lactamase Occurrence in USA (2012-2014) and Activity of CAZ-AVI Against a Large Collection of BL Producing Isolates, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
CAZ-AVI Activity against Aerobic Gram-negative Organisms Isolated from IAI in USA Hospitals (2012-2014)
CAZ-AVI Activity against Aerobic Gram-negative Organisms Isolated from IAI in USA Hospitals (2012-2014), Lead author: Sader HS, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Antimicrobial Activity of Ceftaroline and Comparator Agents when Tested Against Numerous Species of CoNS
Antimicrobial Activity of Ceftaroline and Comparator Agents when Tested Against Numerous Species of CoNS, Lead author: Sader HS, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Update of Oritavancin ad Comparator Agent Activities Against Gram-Positive Isolates Responsible for Documented SSSI in the USA (2014)
Update of Oritavancin ad Comparator Agent Activities Against Gram-Positive Isolates Responsible for Documented SSSI in the USA (2014), Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Update of Telavancin in vitro Activity Against a USA collection of Gram-Positive Clinical Isolates (2014) Causing Skin and Skin Structure Infections
Update of Telavancin in vitro Activity Against a USA collection of Gram-Positive Clinical Isolates (2014) Causing Skin and Skin Structure Infections, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
In Vitro Activity of Tedizolid against Streptococci and Enterococci Isolated from the United States and Europe in 2014
In Vitro Activity of Tedizolid against Streptococci and Enterococci Isolated from the United States and Europe in 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Oritavancin In Vitro Activity Against a Collection of Molecularly-characterized Staph and Enterococci with Elevated Linezolid MICs
Oritavancin In Vitro Activity Against a Collection of Molecularly-characterized Staph and Enterococci with Elevated Linezolid MICs, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of a Long-acting Echincandin (CD101) and Comparator Antifungal Agents against Contemporary Invasive Fungal Isolates
Activity of a Long-acting Echincandin (CD101) and Comparator Antifungal Agents against Contemporary Invasive Fungal Isolates, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
In Vitro Activity of Pexiganan Tested Against Pathogens with Elevated MICs to Topical Antimicrobials
In Vitro Activity of Pexiganan Tested Against Pathogens with Elevated MICs to Topical Antimicrobials, Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of Omadacycline Tested Against S. aureus from a Global Surveillance Program (2014)
Activity of Omadacycline Tested Against S. aureus from a Global Surveillance Program (2014), Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of Solithromycin Against Pathogens Associated with CABP: Global Surveillance Results from 2014
Activity of Solithromycin Against Pathogens Associated with CABP: Global Surveillance Results from 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Performance of BD MAX™ StaphSR against S. aureus Clinical Isolates from the 9 USA Census Regions
Performance of BD MAX™ StaphSR against S. aureus Clinical Isolates from the 9 USA Census Regions, Lead author: Mendes RE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Evaluation of Carbapenemase Detection Methods Using a Challenging Collection of Enterobacteriaceae Isolates
Evaluation of Carbapenemase Detection Methods Using a Challenging Collection of Enterobacteriaceae Isolates, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Solithromycin MIC and Disk Diffusion Quality Control Ranges, a CLSI Multi-Laboratory M23-A3 Study Design
Solithromycin MIC and Disk Diffusion Quality Control Ranges, a CLSI Multi-Laboratory M23-A3 Study Design, Lead author: Ross JE, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Plazomicin (PLZ) Activity Against Contemporary Clinical Isolates Collected in USA Hospitals
Plazomicin (PLZ) Activity Against Contemporary Clinical Isolates Collected in USA Hospitals, Lead author: Castanheira M, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of Omadacycline Tested against Enterobacteriaceae Causing Urinary Tract Infections from a Global Surveillance Porgram (2014)
Activity of Omadacycline Tested against Enterobacteriaceae Causing Urinary Tract Infections from a Global Surveillance Porgram (2014), Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Ceftobiprole Activity When Tested Against Clinical Bacterial Pathogens from Europe, Turkey and Israel 2014
Ceftobiprole Activity When Tested Against Clinical Bacterial Pathogens from Europe, Turkey and Israel 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Activity of Lefamulin, an Pleuromutilin Derivative, against S. aureus Strains with Decreased Susceptibility to Vancomycin
Activity of Lefamulin, an Pleuromutilin Derivative, against S. aureus Strains with Decreased Susceptibility to Vancomycin, Lead author: Sader HS, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Report of Linezolid Activity from the ZAAPS Program 2014 (EU, LA, APAC, Cananda)
Report of Linezolid Activity from the ZAAPS Program 2014 (EU, LA, APAC, Cananda), Lead author: Flamm RK, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
In vitro Activity of Tedizolid Against Gram-positive Pathogens Isolated from Patients SSSI in the US and EU During 2014
In vitro Activity of Tedizolid Against Gram-positive Pathogens Isolated from Patients SSSI in the US and EU During 2014, Lead author: Farrell DJ, presented at 55th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17-21,2015, San Diego, CA
Sustained potent activity of dalbavancin when tested against MDR staphylococcal and streptococcal isolates responsible for documented infection in EU (2011-2013)
Sustained potent activity of dalbavancin when tested against MDR staphylococcal and streptococcal isolates responsible for documented infection in EU (2011-2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
In vitro activity of oritavancin against streptococci, including macrolide- and/or lincosamide (constitutive)-resistant and MDR isolates from EU hospitals (2010-2013)
In vitro activity of oritavancin against streptococci, including macrolide- and/or lincosamide (constitutive)-resistant and MDR isolates from EU hospitals (2010-2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Tigecycline activity tested against >11,000 isolates of Acinetobacter spp. collected worldwide in 2004-2013
Tigecycline activity tested against >11,000 isolates of Acinetobacter spp. collected worldwide in 2004-2013, Lead author: Sader HS, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Debio 1452 MIC QC Range with S. aureus ATCC 29213 Using a Multi-laboratory Study Design
Debio 1452 MIC QC Range with S. aureus ATCC 29213 Using a Multi-laboratory Study Design, Lead author: Flamm RK, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Accuracy of Predicting Oritavancin Susceptibility using Vancomycin Surrogate Susceptibility Testing of GP from EU
Accuracy of Predicting Oritavancin Susceptibility using Vancomycin Surrogate Susceptibility Testing of GP from EU, Lead author: Jones RN, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Minocycline activity tested against A. baumannii, B. cepacia, S. maltophila, and select Enterobacteriaceae isolates from a European surveillance program (2013)
Minocycline activity tested against A. baumannii, B. cepacia, S. maltophila, and select Enterobacteriaceae isolates from a European surveillance program (2013), Lead author: Flamm RK, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Update on dalbavancin activity tested against Gram-positive isolates causing documented skin and soft tissue infections in USA and European hospitals (2011-2013)
Update on dalbavancin activity tested against Gram-positive isolates causing documented skin and soft tissue infections in USA and European hospitals (2011-2013), Lead author: Medes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Antimicrobial potency of lefamulin (BC-3781) tested against S. pneumoniae with defined serotypes, including MDR isolates causing lower RTI in the USA
Antimicrobial potency of lefamulin (BC-3781) tested against S. pneumoniae with defined serotypes, including MDR isolates causing lower RTI in the USA, Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Potent in vitro activity of telavancin against EU strep. isolates displaying an array of antibiogram profiles
Potent in vitro activity of telavancin against EU strep. isolates displaying an array of antibiogram profiles, Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Antimicrobial Activity of Ceftolozane/Tazobactam and Comparator Agents Tested against Pseudomonas aeruginosa Isolates from 15 European Countries and Israel (2013)
Antimicrobial Activity of Ceftolozane/Tazobactam and Comparator Agents Tested against Pseudomonas aeruginosa Isolates from 15 European Countries and Israel (2013), Lead author: Sader HS, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Molecular characterization of genes encoding CTX-M-134, TEM-207 and TEM-212 detected among Escherichia coli clinical isolates from USA hospitals
Molecular characterization of genes encoding CTX-M-134, TEM-207 and TEM-212 detected among Escherichia coli clinical isolates from USA hospitals, Lead author: Castanheira M, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
In vitro activity of dalbavancin tested against S. pneumoniae responsible for documented infection in medical centres in five continents worldwide (2011-2013)
In vitro activity of dalbavancin tested against S. pneumoniae responsible for documented infection in medical centres in five continents worldwide (2011-2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Oritavancin in vitro activity against the most prevalent antibiogram resistance patterns among MRSA, including MDR strains from patients in European hospitals (2010-2013)
Oritavancin in vitro activity against the most prevalent antibiogram resistance patterns among MRSA, including MDR strains from patients in European hospitals (2010-2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Update of the telavancin in vitro activity against SA and CoNS, including isolates with decreasing susceptibility for comparator agents in European hospitals (2013)
Update of the telavancin in vitro activity against SA and CoNS, including isolates with decreasing susceptibility for comparator agents in European hospitals (2013), Lead author: Mendes RE, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Maximizing antibacterial activity of polymyxin B: Microbiological component analyses alone and in combination
Maximizing antibacterial activity of polymyxin B: Microbiological component analyses alone and in combination, Lead author: Kassamali Z, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Antimicrobial Activity of Ceftolozane/Tazobactam and Comparator Agents Tested against Enterobacteriaceae Isolates from 15 European Countries and Israel (2013)
Antimicrobial Activity of Ceftolozane/Tazobactam and Comparator Agents Tested against Enterobacteriaceae Isolates from 15 European Countries and Israel (2013), Lead author: Farrell DJ, presented at 25th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 25-29, 2015, Copenhagen, Denmark
Baseline activity of telavancin when tested against Gram-positive clinical isolates responsible for documented infections in USA hospitals (2011-2012) applying the revised susceptibility testing method.
Baseline activity of telavancin when tested against Gram-positive clinical isolates responsible for documented infections in USA hospitals (2011-2012) applying the revised susceptibility testing method. by Mendes RE, Farrell DJ, Sader HS, Flamm RK and Jones RN published in Antimicrob. Agents Chemother. 2015; 59 (1): 702-706
In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against gram-positive, fastidious gram-negative, and atypical bacteria.
In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against gram-positive, fastidious gram-negative, and atypical bacteria. by Huband MD, Bradford PA, Otterson LG, Basarab GS, Kutschke AC, Giacobbe RA, Patey SA, Alm RA, Johnstone MR, Potter ME, Miller PF and Mueller JP published in Antimicrob. Agents Chemother. 2015; 59 (1): 467-474
Telavancin in vitro activity against a USA collection of methicillin-resistant Staphylococcus aureus, including resistant subsets.
Telavancin in vitro activity against a USA collection of methicillin-resistant Staphylococcus aureus, including resistant subsets. by Mendes RE, Sader HS, Flamm RK, Farrell DJ and Jones RN published in Antimicrob. Agents Chemother. 2015; 59 (3): 1811-1814
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms.
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms. by Flamm RK, Rhomberg PR, Simpson KM, Farrell DJ, Sader HS and Jones RN published in Antimicrob. Agents Chemother. 2015; 59 (3): 1751-1754
